Growth suppression of low HER-2/neu-expressing breast cancer cell line MDA-MB-435 by tyrosine kinase inhibitor emodin

Oncology Reports

Volumn 3, Issue 3, 1996, Pages 509-511

  Ueno, Naoto T ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Breast neoplasms; Emodin; HER 2; Neu; Tyrosine kinase

Indexed keywords

EMODIN; PROTEIN TYROSINE KINASE INHIBITOR;

ARTICLE; BREAST CANCER; CONTROLLED STUDY; GENE EXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; ONCOGENE NEU; PRIORITY JOURNAL; TUMOR CELL LINE;

EID: 0029925180     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.3.3.509     Document Type: Article

References (2)

1. Hung MC, Schlechter AL, Chevray PY, Stern DF and Weinberg R: A molecular cloning of the neu gene: absence of gross structural alteration in oncogenic alleles. Proc Natl Acad Sei USA 83: 261-264, 1986.
2. Schechter AL, Hung MC, Vaidyanathan L, Weinberg RA, Yang FT, Franckc U, Ullrich A and Coussens L: The neu gene: an eriB-homologous gene distinct from and unlinked to the gene encoding the EOF receptor. Science 229: 976-978, 1985.